Health officials are reminding the public that antibiotics are ineffective against respiratory infections caused by viruses, ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The findings come on the cusp of the Northern Hemisphere flu and respiratory syncytial virus seasons and rising US COVID-19 ...

Upper respiratory infections (URIs) are some of the most common infections and are caused by a variety of pathogens. Treatment for URIs is usually symptomatic only, if needed, unless a person also has ...

aDepartment of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent ...

Despite patients with chronic respiratory diseases commonly being ... Among COPD patients, the effectiveness of PPV in preventing pneumonia and/or acute infective exacerbations is unclear.

respiratory syncytial virus (RSV). RSV typically causes mild, cold-like symptoms, shortness of breath, tiredness and fever, but can also lead to severe lung infections like pneumonia and infant ...

Every year, thousands of people in your age group need hospital care for RSV infection. RSV can make it difficult to breathe and can lead to severe problems like pneumonia ... RSV is a respiratory ...

Respiratory virus season is right around the corner. Although rates are still nowhere close to where they were during 2022’s omicron wave, percent positivity remains high and was higher in late ...

It’s the second time in two years that the mpox virus is on the move. This time, a new, faster-spreading variant is flitting across continents and sparking concerns of another serious epidemic.